InnoMedCatalyst (Catalysing the regional innovation capacity of the MEDICNEST Digital Precision Medicine ecosystem and beyond)
IMAGO-MOL is partner in the InnoMedCatalyst project (Catalysing the regional innovation capacity of the MEDICNEST Digital Precision Medicine ecosystem and beyond), funded through the I3-cap2b program. The project consortium consists of 13 partners from 10 European regions across 8 countries (Romania, Spain, Belgium, Bulgaria, Italy, Greece, Poland, and Portugal) and is coordinated by the North-East Regional Development Agency. The InnoMedCatalyst project aims to enhance the regional innovation capacity of the precision and personalized medicine ecosystems across Europe, where startups, spinoffs, scaleups, innovators and healthcare providers [...]